Rising Burden of Psychiatric and Behavioral Disorders and Their Adverse Impact on Health Care Expenditure in

Aravind Thavamani1, Jasmine Khatana2, Krishna Kishore Umapathi3

  • 1Division of Pediatric Gastroenterology, Hepatology and Nutrition, UH Rainbow Babies and Children's Hospital, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Insights

The prevalence of psychiatric disorders in hospitalized pediatric inflammatory bowel disease (IBD) patients is rising. These conditions independently increase hospital stays and costs for IBD care.

Area of Science:

  • Pediatric Gastroenterology
  • Child Psychiatry
  • Health Services Research

Background:

  • Increasing incidence and prevalence of inflammatory bowel disease (IBD).
  • Rising rates of comorbid psychiatric and behavioral disorders in IBD patients.
  • Psychiatric disorders are independent predictors of quality of life in IBD.

Purpose of the Study:

  • To analyze the prevalence of psychiatric and behavioral disorders in hospitalized pediatric IBD patients.
  • To compare outcomes between IBD patients with and without psychiatric/behavioral disorders.
  • To assess the impact of these comorbidities on IBD severity, length of stay, and hospitalization charges.

Main Methods:

  • Analysis of non-overlapping years (2003-2016) from the National Inpatient Sample and Kids Inpatient Database.
  • Inclusion of all IBD-related hospitalizations for patients under 21 years of age.
  • Comparison of IBD patients with and without concomitant psychiatric/behavioral disorder diagnoses.

Main Results:

  • A total of 161,294 IBD hospitalizations were analyzed; 15.7% had psychiatric/behavioral disorders.
  • Prevalence of these disorders increased from 11.3% (2003) to 20.6% (2016) (p<0.001).
  • Psychiatric disorders were associated with increased IBD severity, longer hospital stays (1.17 additional days), and higher charges ($8473 additional).

Conclusions:

  • The prevalence of psychiatric and behavioral disorders in hospitalized pediatric IBD patients has significantly increased.
  • These comorbidities are independently associated with prolonged hospital stays.
  • Higher total hospitalization charges are linked to psychiatric and behavioral disorders in pediatric IBD patients.
Abstract

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
514
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
331
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
265
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
169
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
384
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
184